title: Short- and long-term effect of interferon therapy for chronic hepatitis C.
abstract: OBJECTIVE
  To study the short and long-term effect of interferon therapy for chronic hepatitis C.
  
  
  METHODS
  Sixty-eight patients with chronic hepatitis C were treated with interferon (3 × 10(6) IU, im/2 d, for a course of three months) with 1 to 5 courses of treatment and followed for 1.5 to 3 years after the therapy.
  
  
  RESULTS
  According to antiviral effect of interferon, 76.5% (52/68) of the cases had a complete response by the end of the first therapy course, while 20.6% (14/68) and 2.9% (2/68) had a partial response or non-response. Over a half of the patients with a complete response (27/52, 51.9%) relapsed within 6 to 10 mo after the first course. Of the original cohort, nineteen patients received two courses of therapy, while one patient received three and another three received five courses of therapy. The follow-up for these patients was between 1.5 to 3 years, at which time 29 (42.7%) of the patients sustained a complete response, with four of them having HCV RNA positive serum, while the others had either a partial (37/68, 2.9%) or non-response.
  
  
  CONCLUSIONS
  Interferon therapy had a high short-term complete response but a low long-term complete response in the treatment of chronic hepatitis C.
authors.affiliation: Zhen-Ya Tang, Jun-Ying Qi, Han-Xing Shen, Dong-Liang Yang, Lian-Jie Hao, Clinical Immunology Research Unit, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China.
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Tang
authors.affiliation: Zhen-Ya Tang, Jun-Ying Qi, Han-Xing Shen, Dong-Liang Yang, Lian-Jie Hao, Clinical Immunology Research Unit, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China.
authors.forename: J Y
authors.initials: JY
authors.lastname: Qi
authors.affiliation: Zhen-Ya Tang, Jun-Ying Qi, Han-Xing Shen, Dong-Liang Yang, Lian-Jie Hao, Clinical Immunology Research Unit, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China.
authors.forename: H X
authors.initials: HX
authors.lastname: Shen
authors.affiliation: Zhen-Ya Tang, Jun-Ying Qi, Han-Xing Shen, Dong-Liang Yang, Lian-Jie Hao, Clinical Immunology Research Unit, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China.
authors.forename: D L
authors.initials: DL
authors.lastname: Yang
authors.affiliation: Zhen-Ya Tang, Jun-Ying Qi, Han-Xing Shen, Dong-Liang Yang, Lian-Jie Hao, Clinical Immunology Research Unit, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan 430030, Hubei Province, China.
authors.forename: L J
authors.initials: LJ
authors.lastname: Hao
keywords: Hepatitis C/therapy; Interferons/therapeutic use